Grants and Contracts per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
Doctor of Philosophy, University Of North Carolina
1995
Bachelor of Science in Pharmacy, Auburn University
1989
Fingerprint
Dive into the research topics where Charles Loftin is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration from the last 5 years on country level. Dive into details by clicking on the dots.
Grants and Contracts
- 20 Finished
-
Fellowship for Julie Oestreich: The Effects of P2Y12 Polymorphisms on Platelet Receptor Expression and Activation
Loftin, C. & Oestreich, J.
7/1/08 → 3/31/09
Project: Research project
-
Prostanoid-dependent Abdominal Aortic Aneurysm Formation
National Heart Lung and Blood Institute
5/1/07 → 5/1/07
Project: Research project
-
Prostanoid-dependent Abdominal Aortic Aneurysm Formation
National Heart Lung and Blood Institute
5/1/07 → 4/30/13
Project: Research project
-
Julie Oestreich Fellowship: The Effects of P2Y12 Polymorphism on Platelet Receptor Density and Activation
Loftin, C., Oestreich, J. & Wedlund, P.
American Heart Association Ohio Valley Affiliate
7/1/06 → 6/30/08
Project: Research project
-
Center for the Biological Basis of Oral/Systemic Disease: Project 2 Loftin
Loftin, C. & Tai, H.
National Center for Research Resources
9/23/04 → 9/29/09
Project: Research project
-
Analgesic effects of a highly selective mPGES-1 inhibitor
Stewart, M. J., Weaver, L. M., Ding, K., Kyomuhangi, A., Loftin, C. D., Zheng, F. & Zhan, C. G., Dec 2023, In: Scientific Reports. 13, 1, 3326.Research output: Contribution to journal › Article › peer-review
Open Access -
Development of pharmacotherapies for abdominal aortic aneurysms
Weaver, L. M., Loftin, C. D. & Zhan, C. G., Sep 2022, In: Biomedicine and Pharmacotherapy. 153, 113340.Research output: Contribution to journal › Review article › peer-review
Open Access4 Scopus citations -
DREAM-in-CDM Approach and Identification of a New Generation of Anti-inflammatory Drugs Targeting mPGES-1
Zhou, S., Zhou, Z., Ding, K., Yuan, Y., Loftin, C., Zheng, F. & Zhan, C. G., Dec 1 2020, In: Scientific Reports. 10, 1, 10187.Research output: Contribution to journal › Article › peer-review
Open Access12 Scopus citations -
Structure-based discovery of mPGES-1 inhibitors suitable for preclinical testing in wild-type mice as a new generation of anti-inflammatory drugs
Ding, K., Zhou, Z., Hou, S., Yuan, Y., Zhou, S., Zheng, X., Chen, J., Loftin, C., Zheng, F. & Zhan, C. G., Dec 1 2018, In: Scientific Reports. 8, 1, 5205.Research output: Contribution to journal › Article › peer-review
Open Access34 Scopus citations -
Microsomal Prostaglandin E Synthase-1 Expression by Aortic Smooth Muscle Cells Attenuates the Differentiated Phenotype
Adedoyin, O. O. & Loftin, C. D., Aug 1 2016, In: Journal of Cardiovascular Pharmacology. 68, 2, p. 127-142 16 p.Research output: Contribution to journal › Article › peer-review
3 Scopus citations